**Core Concept:** Cholestasis is a condition characterized by decreased bile flow, leading to elevated serum alkaline phosphatase levels and cholestasis index. Cholestasis can be caused by various factors, including gallstones, liver diseases, and medications. Cholestasis can lead to various complications such as pruritus, liver fibrosis, and liver cirrhosis. Cholestasis can be classified into primary (e.g., primary biliary cholangitis) and secondary (e.g., drug-induced cholestasis). Cholestasis can be associated with various complications and clinical presentations.

**Why the Correct Answer is Right:** Cholestasis due to drug-induced cholestasis is a known complication of certain medications, including Cholestyramine. Cholestyramine is a binding resin used as a medication to lower cholesterol levels in patients with hyperlipidemia. It works by binding to bile acids, preventing their reabsorption in the gut and increasing fecal excretion of bile acids. This leads to compensatory hypersecretion of bile acids by the liver, resulting in cholestasis.

**Why Each Wrong Option is Incorrect:**

A. Gallstones: Gallstones are not the primary cause of cholestasis due to Cholestyramine. Cholestasis due to gallstones usually presents with symptoms like abdominal pain, fever, and cholangitis, which are not directly related to Cholestyramine use.

B. Liver disease: Liver disease can lead to cholestasis, but it is not the correct answer for Cholestyramine-induced cholestasis. Liver diseases can cause primary or secondary cholestasis, but the question specifically asks about Cholestyramine-induced cholestasis.

C. Cholestyramine itself: Cholestyramine causes cholestasis as a side effect, not as a primary cause. The question asks for the cause of cholestasis due to Cholestyramine, not the drug itself.

D. Cholestyramine-induced liver disease: This option is incorrect because Cholestyramine-induced liver disease would not specifically mention cholestasis as a complication. The question asks for the cause of cholestasis due to Cholestyramine rather than focusing on liver disease.

**Clinical Pearls:** Cholestyramine-induced cholestasis is a rare but known side effect of Cholestyramine use. It is essential for physicians to be aware of this side effect when prescribing Cholestyramine to patients, especially those with underlying liver disease or coexisting medications that may interact with Cholestyramine. Understanding the mechanism of cholestasis due to Cholestyramine helps in managing patients properly and preventing adverse effects.